Shawn X. Sun

2.3k total citations · 1 hit paper
57 papers, 1.7k citations indexed

About

Shawn X. Sun is a scholar working on Pulmonary and Respiratory Medicine, Physiology and Cardiology and Cardiovascular Medicine. According to data from OpenAlex, Shawn X. Sun has authored 57 papers receiving a total of 1.7k indexed citations (citations by other indexed papers that have themselves been cited), including 20 papers in Pulmonary and Respiratory Medicine, 14 papers in Physiology and 13 papers in Cardiology and Cardiovascular Medicine. Recurrent topics in Shawn X. Sun's work include Chronic Obstructive Pulmonary Disease (COPD) Research (16 papers), Asthma and respiratory diseases (13 papers) and Health Systems, Economic Evaluations, Quality of Life (9 papers). Shawn X. Sun is often cited by papers focused on Chronic Obstructive Pulmonary Disease (COPD) Research (16 papers), Asthma and respiratory diseases (13 papers) and Health Systems, Economic Evaluations, Quality of Life (9 papers). Shawn X. Sun collaborates with scholars based in United States, India and United Kingdom. Shawn X. Sun's co-authors include Gordon G. Liu, Xuemei Luo, Ricardo Pietrobon, Lloyd A. Hey, Frank R. Lichtenberg, Dale B. Christensen, Alex Z. Fu, Reema Mody, Jan-Samuel Wagner and Marco DiBonaventura and has published in prestigious journals such as Circulation, Blood and Spine.

In The Last Decade

Shawn X. Sun

55 papers receiving 1.7k citations

Hit Papers

Estimates and Patterns of... 2003 2026 2010 2018 2003 200 400 600

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Shawn X. Sun United States 16 610 357 314 312 276 57 1.7k
Hind T. Hatoum United States 24 338 0.6× 47 0.1× 421 1.3× 232 0.7× 133 0.5× 72 2.0k
Jeffrey I. Mechanick United States 12 525 0.9× 259 0.7× 578 1.8× 61 0.2× 119 0.4× 19 3.6k
Marcia F.T. Rupnow United States 28 126 0.2× 730 2.0× 498 1.6× 208 0.7× 1.6k 5.7× 63 2.6k
Winghan Jacqueline Kwong United States 21 129 0.2× 91 0.3× 171 0.5× 179 0.6× 326 1.2× 70 1.4k
Elizabeth M Haney United States 23 153 0.3× 569 1.6× 317 1.0× 77 0.2× 272 1.0× 43 2.1k
Con Kelleher United Kingdom 32 179 0.3× 115 0.3× 1.4k 4.4× 158 0.5× 279 1.0× 88 6.9k
Debra A. Heller United States 15 121 0.2× 87 0.2× 285 0.9× 93 0.3× 88 0.3× 29 1.5k
Joshua N. Liberman United States 28 246 0.4× 1.3k 3.5× 361 1.1× 751 2.4× 2.3k 8.3× 58 4.4k
Randy L. Fought United States 13 213 0.3× 38 0.1× 268 0.9× 202 0.6× 396 1.4× 14 1.6k
Kris L. L. Movig Netherlands 20 184 0.3× 128 0.4× 131 0.4× 39 0.1× 210 0.8× 59 1.4k

Countries citing papers authored by Shawn X. Sun

Since Specialization
Citations

This map shows the geographic impact of Shawn X. Sun's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Shawn X. Sun with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Shawn X. Sun more than expected).

Fields of papers citing papers by Shawn X. Sun

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Shawn X. Sun. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Shawn X. Sun. The network helps show where Shawn X. Sun may publish in the future.

Co-authorship network of co-authors of Shawn X. Sun

This figure shows the co-authorship network connecting the top 25 collaborators of Shawn X. Sun. A scholar is included among the top collaborators of Shawn X. Sun based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Shawn X. Sun. Shawn X. Sun is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Sun, Shawn X., et al.. (2024). The Current Landscape of Artificial Intelligence in Imaging for Transcatheter Aortic Valve Replacement. Current Radiology Reports. 12(11-12). 113–120. 4 indexed citations
2.
Sun, Shawn X., et al.. (2023). Outcomes in Patients With von Willebrand Disease Receiving Recombinant von Willebrand Factor on Demand and in Surgical Settings: Chart Review. Clinical and Applied Thrombosis/Hemostasis. 29. 2995358798–2995358798. 3 indexed citations
3.
Sun, Shawn X., et al.. (2023). Microsimulation to compare activity-related bleed risks between pharmacokinetic-guided rurioctocog alfa pegol prophylaxis and emicizumab. Expert Review of Hematology. 16(3). 205–211. 1 indexed citations
4.
Du, Ping, et al.. (2022). Disease Burden in Patients with von Willebrand Disease Potentially Eligible for Prophylaxis: Post Hoc Analysis of a European Cross-Sectional Study. Clinical and Applied Thrombosis/Hemostasis. 28. 2985311838–2985311838. 3 indexed citations
6.
Casale, Thomas B., et al.. (2018). Reslizumab Compared with Benralizumab in Patients with Eosinophilic Asthma: A Systematic Literature Review and Network Meta-Analysis. The Journal of Allergy and Clinical Immunology In Practice. 7(1). 122–130.e1. 41 indexed citations
7.
Marsh, Kevin, et al.. (2016). Evaluation of COPD Treatments: A Multicriteria Decision Analysis of Aclidinium and Tiotropium in the United States. Value in Health. 20(1). 132–140. 15 indexed citations
8.
Jain, Rahul, Qian Cai, Shawn X. Sun, & Hiangkiat Tan. (2015). Roflumilast: Who Is Using It and How It Affects Health Care Resource Utilization and Costs.. PubMed. 24(8). 40–8. 1 indexed citations
9.
Fu, Alex Z., Shawn X. Sun, Xingyue Huang, & Alpesh Amin. (2013). 30-Day Readmission Rate Associated With Roflumilast Treatment Among Patients Hospitalized for COPD. CHEST Journal. 144(4). 744A–744A. 1 indexed citations
10.
Macaulay, Dendy, et al.. (2013). Development and validation of a claims-based prediction model for COPD severity. Respiratory Medicine. 107(10). 1568–1577. 26 indexed citations
11.
AbuDagga, Azza, Shawn X. Sun, Hiangkiat Tan, & Caitlyn T. Solem. (2013). Healthcare utilization and costs among chronic bronchitis patients treated with maintenance medications from a US managed care population. Journal of Medical Economics. 16(3). 421–429. 9 indexed citations
12.
Solem, Caitlyn T., Shawn X. Sun, Cynthia Macahilig, Monica Katyal, & Xīn Gào. (2012). Burden of COPD Exacerbations in Severe and Very Severe COPD Patients: Initial Results of a Nationally Representative Patient Survey and Chart Revie. CHEST Journal. 142(4). 718A–718A. 1 indexed citations
13.
Rennard, Stephen I., Shawn X. Sun, Stavros Tourkodimitris, et al.. (2012). Effect Of Roflumilast Treatment Added To Tiotropium On Dyspnea In Patients With Chronic Obstructive Pulmonary Disease. A2261–A2261. 2 indexed citations
14.
Sun, Shawn X., Maryna Marynchenko, Ritesh Banerjee, et al.. (2011). Cost-effectiveness analysis of roflumilast/tiotropium therapy versus tiotropium monotherapy for treating severe-to-very severe COPD. Journal of Medical Economics. 14(6). 805–815. 10 indexed citations
17.
Sun, Shawn X., et al.. (2007). The Medicare Part D doughnut hole: effect on pharmacy utilization.. PubMed. 20(9). 51–5, 59. 16 indexed citations
18.
Sun, Shawn X., Gordon G. Liu, Dale B. Christensen, & Alex Z. Fu. (2007). Review and analysis of hospitalization costs associated with antipsychotic nonadherence in the treatment of schizophrenia in the United States. Current Medical Research and Opinion. 23(10). 2305–2312. 174 indexed citations
19.
Liu, Gordon G., Shawn X. Sun, Dale B. Christensen, & Zhongyun Zhao. (2005). Choice of atypical antipsychotic therapy for patients with schizophrenia: An analysis of a medicaid population. Current Therapeutic Research. 66(5). 463–474. 3 indexed citations
20.
Moore, Lisa E., Tarshi Droma, R. E. McCullough, et al.. (1992). Are Tibetans Better Adapted?. International Journal of Sports Medicine. 13(S 1). S86–S88. 52 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026